martes, 6 de junio de 2023

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

https://www.nejm.org/doi/full/10.1056/NEJMoa2304594?query=featured_home

No hay comentarios:

Publicar un comentario